Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FX2DB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,706
Award facts
- Contract value 100% obligated
- $73,706.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $73,706.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, issued on August 25, 2025, is scheduled for ultimate completion by September 16, 2025, with performance occurring at the vendor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The Keytruda procurement supports oncology treatment needs within the military healthcare system, aligning with the broader mission of the Defense Logistics Agency to provide essential medical supplies to defense infrastructure.
Quick answers
Who was awarded contract SPE2DB25FX2DB?
SPE2DB25FX2DB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FX2DB worth?
The government has obligated $73,706 on SPE2DB25FX2DB.
Is contract SPE2DB25FX2DB an order under another contract?
Yes. SPE2DB25FX2DB is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2DB competed?
The extent of competition for SPE2DB25FX2DB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award